Key facts
- This page summarizes Martin P. Sutter's Form 4 filing for ABIOMED INC.
- 18 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 19 May 2022, 16:49.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Additional SEC filing notes
Footnote F1
Sale of common stock pursuant to reporting owner's 10b5-1 plan.
Footnote F2
This price represents the sale price of the transactions on the reported date at $256.5303. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Footnote F3
This price represents the sale price of the transactions on the reported date at $257.5059. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Footnote F4
This price represents the sale price of the transactions on the reported date at $258.2408. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Footnote F5
This price represents the sale price of the transactions on the reported date at $259.1506. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Footnote F6
This price represents the sale price of the transactions on the reported date at $261.5526. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Footnote F7
This price represents the sale price of the transactions on the reported date at $262.1800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Footnote F8
This price represents the sale price of the transactions on the reported date at $240.0713. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Footnote F9
This price represents the sale price of the transactions on the reported date at $240.6810. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Footnote F10
This price represents the sale price of the transactions on the reported date at $241.8429. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Footnote F11
This price represents the sale price of the transactions on the reported date at $242.7737. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Footnote F12
This price represents the sale price of the transactions on the reported date at $244.3156. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Footnote F13
This price represents the sale price of the transactions on the reported date at $245.6645. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Footnote F14
This price represents the sale price of the transactions on the reported date at $246.7770. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Footnote F15
This price represents the sale price of the transactions on the reported date at $247.5948. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Footnote F16
This price represents the sale price of the transactions on the reported date at $249.7451. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Footnote F17
This price represents the sale price of the transactions on the reported date at $250.8185. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Footnote F18
This price represents the sale price of the transactions on the reported date at $251.8512. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Footnote F19
This price represents the sale price of the transactions on the reported date at $253.2200. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer